Structural basis of AMPA receptor inhibition by trans-4-butylcyclohexane carboxylic acid.
Yelshanskaya, M.V., Singh, A.K., Narangoda, C., Williams, R.S.B., Kurnikova, M.G., Sobolevsky, A.I.(2022) Br J Pharmacol 179: 3628-3644
- PubMed: 32959886 
- DOI: https://doi.org/10.1111/bph.15254
- Primary Citation of Related Structures:  
6XSR - PubMed Abstract: 
AMPA receptors, which shape excitatory postsynaptic currents and are directly involved in overactivation of synaptic function during seizures, represent a well-accepted target for anti-epileptic drugs. Trans-4-butylcyclohexane carboxylic acid (4-BCCA) has emerged as a new promising anti-epileptic drug in several in vitro and in vivo seizure models, but the mechanism of its action remained unknown. The purpose of this study is to characterize structure and dynamics of 4-BCCA interaction with AMPA receptors.
Organizational Affiliation: 
Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.